Chronic Lymphocytic Leukemia minimal residual disease (CLL-MRD) by flow cytometry : 1017695

Test Code

MDFCPCLLMRD or 1017695

CPT Codes
88184, 88185x9 (for total 10 markers) 88188 (interpretation for 9-15 markers)

Transport Container

Peripheral blood in EDTA or Sodium Heparin
Bone marrow aspirate in EDTA or Sodium Heparin
Do not refrigerate or freeze

Transport Temperature

Room temperature.

Specimen Stability

72 hours at room temperature

Methodology
Flow Cytometry

Setup Schedule

Monday-Saturday

Report Available

1-3 days

Reference Range

By report

Clinical Significance

The assay uses a 10-antibody panel to detect and identify chronic lymphocytic leukemia (CLL) cells from normal B cells in the specimen. The assay provides analytical sensitivity as low as 0.002% to detect and quantify minimal residual disease (MRD) in CLL patients. It can be used to assess remission depth, guide clinical treatment and post treatment monitoring. This assay is not appropriate to diagnose patients with CLL.

Performing Laboratory
med fusion

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.